J Knee Surg 2025; 38(04): 180-187
DOI: 10.1055/s-0044-1793939
Original Article

Patient-Reported Outcomes after Surgery for Pigmented Villonodular Synovitis in the Knee: A Cohort Study

Ryan J. Lashgari
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
Bruce W. Chen
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
Leah E. Henry
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
Sean J. Meredith
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
Jonathan D. Packer
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
,
1   Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland
› Author Affiliations
Funding This work was supported by a grant from the James Lawrence Kernan Hospital Endowment Fund Inc. (BL1941007WS) and in part by Career Development Award Number IK2 BX004879 from the U.S. Department of Veterans Affairs Biomedical Laboratory R&D (BLRD) Service.

Abstract

Pigmented villonodular synovitis (PVNS) is a rare neoplastic proliferation of large joints, including the knee, with both localized PVNS (LPVNS) and diffuse PVNS (DPVNS) types. DPVNS is known to recur at a higher rate following resection; however, there is little evidence comparing patient-reported outcomes (PROs) between the two types. The purpose of this study was to compare PROs between patients with LPVNS and DPVNS involving the knee 2 years after surgical resection. We hypothesized that DPVNS would have worse 2-year PROs than LPVNS.

Sixteen patients who underwent arthroscopic resection of pathology-confirmed PVNS involving the knee were enrolled in a prospective registry. Several PROs, including six Patient-Reported Outcomes Measurement Information System (PROMIS) domains and the International Knee Documentation Committee (IKDC) Subjective Knee Form, were assessed at baseline and at 2 years postoperatively. Mean scores between LPVNS and DPVNS groups were compared using a Wilcoxon exact test, while categorical variables were compared using a Fisher's exact test.

Eleven patients (seven LPVNS and four DPVNS) completed both the baseline and 2-year PRO surveys. There were no significant differences in the demographic variables between groups, including age, body mass index, or prior surgical history (p < 0.05). There was a trend toward higher mean PRO scores in the DPVNS group at 2 years postoperatively in all measures, despite lower reported baseline levels of activity as measured by Marx Activity Rating Scale (26.3 vs. 76.7, p = 0.02). The DPVNS group also trended toward more improvement in PROMIS Physical Function (9.7 vs. −2.7), PROMIS Pain Interference (−9.0 vs. −2.5), PROMIS Anxiety (−5.4 vs. −4.4), and IKDC (26.7 vs. 18.9). However, these differences did not reach statistical significance (p < 0.05). There were two recurrences in the DPVNS group and none in the LPVNS group.

Patients with knee DPVNS do not report worse outcomes 2 years after arthroscopic resection compared with LPVNS patients.



Publication History

Received: 11 April 2024

Accepted: 23 October 2024

Article published online:
28 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Tyler WK, Vidal AF, Williams RJ, Healey JH. Pigmented villonodular synovitis. J Am Acad Orthop Surg 2006; 14 (06) 376-385
  • 2 Verspoor FGM, van der Geest ICM, Vegt E, Veth RPH, van der Graaf WT, Schreuder HWB. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol 2013; 9 (10) 1515-1531
  • 3 Stephan SR, Shallop B, Lackman R, Kim TWB, Mulcahey MK. Pigmented villonodular synovitis: a comprehensive review and proposed treatment algorithm. JBJS Rev 2016; 4 (07) e3
  • 4 Mollon B, Lee A, Busse JW. et al. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J 2015; 97-B (04) 550-557
  • 5 Fang Y, Zhang Q. Recurrence of pigmented villonodular synovitis of the knee: a case report with review of literature on the risk factors causing recurrence. Medicine (Baltimore) 2020; 99 (16) e19856
  • 6 Colman MW, Ye J, Weiss KR, Goodman MA, McGough III RL. Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?. Clin Orthop Relat Res 2013; 471 (03) 883-890
  • 7 Verspoor FGM, Zee AAG, Hannink G, van der Geest ICM, Veth RPH, Schreuder HWB. Long-term follow-up results of primary and recurrent pigmented villonodular synovitis. Rheumatology (Oxford) 2014; 53 (11) 2063-2070
  • 8 Mastboom MJ, Planje R, van de Sande MA. The patient perspective on the impact of tenosynovial giant cell tumors on daily living: crowdsourcing study on physical function and quality of life. Interact J Med Res 2018; 7 (01) e4
  • 9 Mastboom MJL, Palmerini E, Verspoor FGM. et al; TGCT Study Group. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Lancet Oncol 2019; 20 (06) 877-886
  • 10 Yao L, Li Y, Li T. et al. What are the recurrence rates, complications, and functional outcomes after multiportal arthroscopic synovectomy for patients with knee diffuse-type tenosynovial giant-cell tumors?. Clin Orthop Relat Res 2024; 482 (07) 1218-1229
  • 11 Keyhani S, Kazemi SM, Ahn JH, Verdonk R, Soleymanha M. Arthroscopic treatment of diffuse pigmented villonodular synovitis of the knee: complete synovectomy and septum removal-midterm results. J Knee Surg 2019; 32 (05) 427-433
  • 12 Henn III RF, Dubina AG, Jauregui JJ, Smuda MP, Tracy JK. The Maryland Orthopaedic Registry (MOR): design and baseline characteristics of a prospective registry. J Clin Orthop Trauma 2017; 8 (04) 301-307
  • 13 DeWalt DA, Rothrock N, Yount S, Stone AA. PROMIS Cooperative Group. Evaluation of item candidates: the PROMIS qualitative item review. Med Care 2007; 45 (05) S12-S21
  • 14 Anderson AF, Irrgang JJ, Kocher MS, Mann BJ, Harrast JJ. International Knee Documentation Committee. The International Knee Documentation Committee Subjective Knee Evaluation Form: normative data. Am J Sports Med 2006; 34 (01) 128-135
  • 15 Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94 (02) 149-158
  • 16 Johnson C. Measuring pain. Visual analog scale versus numeric pain scale: what is the difference?. J Chiropr Med 2005; 4 (01) 43-44
  • 17 Zywiel MG, Mahomed A, Gandhi R, Perruccio AV, Mahomed NN. Measuring expectations in orthopaedic surgery: a systematic review. Clin Orthop Relat Res 2013; 471 (11) 3446-3456
  • 18 Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res 1976–2007. 1985 ;198:42. Accessed August 1, 2023 at: https://journals.lww.com/corr/abstract/1985/09000/rating_systems_in_the_evaluation_of_knee_ligament.7.aspx
  • 19 Cameron KL, Peck KY, Thompson BS, Svoboda SJ, Owens BD, Marshall SW. Reference values for the Marx Activity Rating Scale in a young athletic population: history of knee ligament injury is associated with higher scores. Sports Health 2015; 7 (05) 403-408
  • 20 Marx RG, Stump TJ, Jones EC, Wickiewicz TL, Warren RF. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med 2001; 29 (02) 213-218
  • 21 Haff R, Lucente V, Raalte H, Olson G, Murphy M. Validation of a new post surgical quality of life tool: the Surgical Satisfaction Questionnaire (SSQ-8). Int Urogynecol J 2009; 20: S133-S133
  • 22 Harris PA, Taylor R, Minor BL. et al; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
  • 23 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 24 Dines JS, DeBerardino TM, Wells JL. et al. Long-term follow-up of surgically treated localized pigmented villonodular synovitis of the knee. Arthroscopy 2007; 23 (09) 930-937
  • 25 Loriaut P, Djian P, Boyer T, Bonvarlet JP, Delin C, Makridis KG. Arthroscopic treatment of localized pigmented villonodular synovitis of the knee. Knee Surg Sports Traumatol Arthrosc 2012; 20 (08) 1550-1553
  • 26 van der Heijden L, Piner SR, van de Sande MAJ. Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients. Int Orthop 2016; 40 (12) 2459-2468
  • 27 Briggs KK, Steadman JR, Hay CJ, Hines SL. Lysholm score and Tegner activity level in individuals with normal knees. Am J Sports Med 2009; 37 (05) 898-901
  • 28 Paradowski PT, Bergman S, Sundén-Lundius A, Lohmander LS, Roos EM. Knee complaints vary with age and gender in the adult population. Population-based reference data for the Knee injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoskelet Disord 2006; 7: 38
  • 29 Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum 2011; 40 (06) 539-546